Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells

[1]  B. Yung,et al.  Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23 , 1998, Oncogene.

[2]  C. Hsu,et al.  Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells , 1998, Oncogene.

[3]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[4]  J. Shay,et al.  Lack of cell cycle regulation of telomerase activity in human cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Riabowol,et al.  Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. , 1996, Cancer research.

[6]  J. Shay,et al.  Regulation of telomerase activity in immortal cell lines , 1996, Molecular and cellular biology.

[7]  E. Dmitrovsky,et al.  Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. , 1996, Cancer research.

[8]  S. Corey,et al.  The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.

[9]  S. Raimondi,et al.  The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.

[10]  A. Sartorelli,et al.  Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Yung,et al.  Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23. , 1995, Biochemical and biophysical research communications.

[12]  J. Shay,et al.  Telomerase activity in gastric cancer. , 1995, Cancer research.

[13]  S. Patterson,et al.  Reduced Numatrin/B23/Nucleophosmin Labeling in Apoptotic Jurkat T-lymphoblasts (*) , 1995, The Journal of Biological Chemistry.

[14]  M. Wu,et al.  Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP. , 1995, The Biochemical journal.

[15]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[16]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[17]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Freeman,et al.  Antisense-mediated specific inhibition of P120 protein expression prevents G1- to S-phase transition. , 1992, Cancer research.

[19]  F. Chang,et al.  Schedule‐dependent effects of two consecutive, divided, low doses of actinomycin D on translocation of protein B23, inhibition of cell growth and RNA synthesis in hela cells , 1992, International journal of cancer.

[20]  J. Shay,et al.  Telomere positional effects and the regulation of cellular senescence. , 1992, Trends in genetics : TIG.

[21]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[22]  J. Gall,et al.  Localization of the nucleolar protein NO38 in amphibian oocytes , 1992, The Journal of cell biology.

[23]  B. Yung,et al.  Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells. , 1990, Cancer research.

[24]  B. Yung,et al.  Immunolocalization of phosphoprotein B23 in proliferating and non‐proliferating hela cells , 1990, International journal of cancer.

[25]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[26]  S. Whittingham,et al.  The nucleotide sequence of a human cDNA encoding the highly conserved nucleolar phosphoprotein B23. , 1989, Biochemical and biophysical research communications.

[27]  P. Chan.  Cross-linkage of nucleophosmin in tumor cells by nitrogen mustard. , 1989, Cancer research.

[28]  Qing-Rong Liu,et al.  Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. , 1989, Biochemistry.

[29]  S. Spiegel,et al.  The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody , 1988, The Journal of cell biology.

[30]  N. Feuerstein,et al.  Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. , 1987, Journal of immunology.

[31]  B. Yung,et al.  Identification and characterization of a hexameric form of nucleolar phosphoprotein B23. , 1987, Biochimica et biophysica acta.

[32]  W. Franke,et al.  A constitutive nucleolar protein identified as a member of the nucleoplasmin family. , 1987, The EMBO journal.

[33]  H. Busch,et al.  Effects of luzopeptins on protein B23 translocation and ribosomal RNA synthesis in HeLa cells. , 1986, Cancer research.

[34]  H. Busch,et al.  Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. , 1985, Biochimica et biophysica acta.

[35]  D. Schmoll,et al.  Comparison of proteins of ribosomal subunits and nucleolar preribosomal particles from Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis. , 1974, Biochemistry.

[36]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[37]  K. Smetana,et al.  The nucleolus of the cancer cell: a review. , 1963, Cancer research.

[38]  A. Tarnawski,et al.  Indomethacin interferes with epidermal growth factor binding and proliferative response of gastric KATO III cells. , 1995, Digestion.